| S. NO | NAME OF INTERMEDIATE | CAS NO. | CATEGORY |
| 1 | 3-(Diethylboraneyl)pyridine | 89878-14-8 | KSM of Abiraterone Acetate |
| 2 | 4-Amino-2-fIuoro-N-methyIbenzamide | 915087-25-1 | KSM of Apalutamide |
| 3 | 2-Fluoro-N-methyl-4-nitrobenzamide | 915087-24-0 | KSM of Apalutamide |
| 4 | 5-Amino-3-(trifluoromethyl) picolinonitriìe | 573762-62-6 | KSM of Apalutamide |
| 5 | 5-Nitro-3-(trif1uoromethyl) picolinonitrile | 573762-57-9 | KSM of Apalutamide |
| 6 | 2-Bromo-5-nitro-3-(trif1uoromethyl)pyridine | 956104-42-0 | KSM of Apalutamide |
| 7 | 4-((1-cyanocycIobutyI)amino)-2-fìuoro-N-methyIbenzamide | 915087-26-2 | Int. for Apalutamide |
| 8 | N-(4-Cyano-3-(trifluromethyl)phenyl)methacrylamide | 90357-53-2 | KSM OF Bicalutamide |
| 9 | N-(4-Cyano-3-(trifluromethyl) phenyl)-2-methyloxirane-2-carboxamide | 90357-51-0 | KSM OF Bicalutamide |
| 10 | (E)-3-ethoxyacryloyl chloride | 6191-99-7 | KSM of Dasatinib |
| 11 | (E)-N-(2-chloro-6-methylphenyl)-3- ethoxyacrylamide | 863127-76-8 | KSM of Dasatinib |
| 12 | 2-amino-N-(2-ch1oro-6-methylphenyl)thiazole-5- carboxamide | 302964-24-5 | KSM of Dasatinib |
| 13 | 2-[(6-Chloro-2-methylpyrimidin-4-yl)amino]-N-(2-chloro-6- methylphenyl)thiazole-5-carboxamide | 302964-08-5 | Int. of Dasatinib |
| 14 | 4-Amino-2-(trifluoromethyl)benzonitrile | 654-70-6 | KSM of Enzalutamide |
| 15 | 4-Nitro-2-(trifluoromethyl)benzonitrile | 320-37-6 | KSM of Enzalutamide |
| 16 | 4-Bromo-3 -(trifluoromethyI)aniline | 393-36-2 | KSM of Enzalutamide |
| 17 | 4-((2-cyanopropan-2-yl)amino)- 2-f1uoro-N-methylbenzamide | 915087-32-0 | Int. of Enzalutamide |
| 18 | Ethyl 3,4dihydroxy benzoate | 3843-89-3 | SM of Erlotinib HCL |
| 19 | 3-(4-phenoxyphenyl)-1 H-pyrazolo[3,4-d]pyrimidin-4-amine | 330786-24-8 | KSM of Ibrutinib |
| 20 | (S)-3-(4-phenoxyphenyl)-1-(piperidine-3yl)-1H-pyrazolo[3,4,d]pyrimidine-4-amine | 1022150-12-4 | Int. of Ibrutinib |
| 1 | 4-((4-methylpiperazin-1 -yl)methyl)benzoic acid | 106261-48-7 | KSM of Imatinib |
| 22 | (E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1 -one | 66521-54-8 | KSM of Imatinib |
| 23 | 4-((4-methyl piperazin-1-yl)methyl)benzonitrile | 125743-63-7 | KSM of Imatinib |
| 24 | 1-(2-methyl-5-nitrophenyl)guanidine | NA | KSM of Imatinib |
| 25 | 4-methylbenzonitrile | 104-85-8 | SM of Imatinib |
Note: Please feel free to contact for additional products requirements if any,
Our team will quickly support on your requirements – info@venrexpharma.com
DISCLAIMER:
PATENTS: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Products currently covered by valid Patents are offered for R&D use only.
Venrex Pharma assumes no responsibility/ liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Venrex Pharma makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.
Venrex Pharma warns the sellers & buyers not to sell / buy any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.